CYSTO-CONRAY II: IOTHALAMATE MEGLUMINE INJECTION.
IOTHALAMATE MEGLUMINE INJECTION. Key specifications include special_features: STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE)., primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 12, primary_container_content_quantity: 250.000 MILLILITERS, active_medicament_medicinal_strength: 17.200 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-100-7986, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE). |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 12 |
| primary_container_content_quantity | 250.000 MILLILITERS |
| active_medicament_medicinal_strength | 17.200 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | IOTHALAMATE MEGLUMINE INJECTION USP 250ML PG OF 12S |
| american_hospital_formulary_service_classification_number | 366800 |
| NSN | 6505-01-100-7986 |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | IOTHALAMATE MEGLUMINE INJECTION USP 17.2% 500ML CONTAINER 12S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 17.200 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 12 |
No substitute or cross-reference records for this part.